Infections and Infectious Diseases

PMT for Severe-CDI

Conditions:   Severe Clostridium Difficile Infection;   Severe-Complicated/Fulminant Clostridium Difficile Infection
Interventions:   Drug: Penn Microbiome Therapy – 001;   Drug: Penn Microbiome Therapy – 002;   Drug: Penn Microbiome Therapy – 003;   Drug: Antibiotics
Sponsor:   University of Pennsylvania
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 31, 2019Comments OffSevereCDI
Read more 
Serial Infusions of Allogeneic Mesenchymal Stem Cells in Ischemic Cardiomyopathy Patients With Left Ventricular Assist Device

Condition:   Ischemic Heart Disease
Interventions:   Biological: Human Allogeneic Mesenchymal Bone Marrow Cells (aMBMC);   Other: Placebo
Sponsor:   Rebecca Torguson
Recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 30, 2019Comments OffAllogeneic | Assist | Cardiomyopathy | Cells | Device | Infusions | Ischemic | Left | Mesenchymal | Patients | Serial | Stem | Ventricular
Read more 
TNP-2092 to Treat Acute Bacterial Skin and Skin Structure Infection

Conditions:   Skin and Subcutaneous Tissue Bacterial Infections;   Gram-Positive Bacterial Infections
Interventions:   Drug: TNP-2092;   Drug: Vancomycin
Sponsor:   TenNor Therapeutics Limited
Recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 29, 2019Comments OffAcute | Bacterial | Infection | Skin | Structure | TNP2092 | Treat
Read more 
The Role of Cytomegalovirus and Inflammation on Patient Symptoms and Outcomes in Ovarian Cancer

Conditions:   Ovarian Cancer;   Fallopian Tube Cancer;   Primary Peritoneal Carcinoma
Intervention:  
Sponsors:   University of Minnesota – Clinical and Translational Science Institute;   United States Department of Defense
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 27, 2019Comments OffCancer | Cytomegalovirus | Inflammation | Outcomes | Ovarian | Patient | Role | Symptoms
Read more 
Safety, Reactogenicity and Immunogenicity of Two Quadrivalent Seasonal Influenza Vaccines (Fluzone(R) or Flublok(R)) With or Without One of Two Adjuvants (AF03 or Advax-CpG55.2) in Healthy Adults

Conditions:   Influenza;   Influenza Immunisation
Interventions:   Biological: Advax-CpG55.2;   Drug: AF03;   Biological: Influenza Virus Quadrivalent Inactivated Vaccine;   Biological: Quadrivalent Recombinant Seasonal Influenza Vaccine
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 26, 2019Comments OffAdjuvants | Adults | AdvaxCpG55.2 | AF03 | FlublokR | FluzoneR | Healthy | Immunogenicity | Influenza | Quadrivalent | Reactogenicity | Safety | Seasonal | Vaccines | Without
Read more 
Avoiding Neuromuscular Blockers to Reduce Complications

Conditions:   Respiratory Failure;   Respiratory Infection;   Aspiration Pneumonia;   Pneumonitis;   Atelectasis;   Bronchospasm
Interventions:   Drug: Neuromuscular Blocking Agents;   Drug: Anesthetic Adjuncts
Sponsor:   Beth Israel Deaconess Medical Center
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 25, 2019Comments OffAvoiding | Blockers | Complications | Neuromuscular | Reduce
Read more 
Efficacy, Safety and Pharmacokinetics Study of Kedrion IVIG 10% to Treat Participants With Primary Immunodeficiency (PID)

Condition:   Primary Immunodeficiency Disease
Intervention:   Biological: Kedrion IVIG 10%
Sponsor:   Kedrion S.p.A.
Recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 24, 2019Comments OffEfficacy | Immunodeficiency | IVIg | Kedrion | Participants | Pharmacokinetics | Primary | Safety | Study | Treat
Read more 
The Validity of the Quick Renal MRI in Pediatric Kidney Disease

Conditions:   Pyelonephritis;   Pyelonephritis Acute;   Renal Sclerosis
Intervention:   Diagnostic Test: Quick MRI
Sponsor:   University of Wisconsin, Madison
Recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 23, 2019Comments OffDisease | Kidney | Pediatric | Quick | Renal | Validity
Read more 
A Study to Evaluate the Safety of MEDI8897 for the Prevention of Medically Attended Respiratory Syncytial Virus(RSV) Lower Respiratory Track Infection (LRTI) in High-risk Children

Condition:   Respiratory Syncytial Virus Infections
Interventions:   Drug: MEDI8897;   Drug: Palivizumab
Sponsor:   MedImmune LLC
Not yet recruiting
ClinicalTrials.gov: Infections_Infectious_Diseases | Recruiting, Not yet recruiting, Available Studies | United States | First posted in the last 100 days

May 22, 2019Comments OffAttended | Children | Evaluate | Highrisk | Infection | Lower | LRTI | MEDI8897 | Medically | Prevention | Respiratory | Safety | Study | Syncytial | Track | VirusRSV
Read more 
Free Clinical Trial Updates

    #1 Best New Product in 2019
    Headache Relief Shampoo Banner Ad
    Search For Clinical Trials
      CLOSE
      Please click to geolocate button to change this value.
      SEARCHRESET
      Featured Research Centers